vTv Therapeutics Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
VTVT on Nasdaq
Industry
Pharmaceutical Preparations
Location
3980 Premier Dr, Suite 310, High Point, NC

Insiders trading volume in the past year

vTv Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Srinivas Akkaraju Director $76.4M Sep 22, 2025
Ronald O. Perelman 10%+ Owner $30.5M Dec 20, 2021
Deepa Prasad President and CEO, Director $29.5M Oct 19, 2021
Samsara BioCapital GP, LLC 10%+ Owner $14M Mar 5, 2024
Paul J. Sekhri Pres, CEO and Exec Chairperson, Director $6.75M +$83.8K +1.26% Mar 1, 2025
Rich S. Nelson Acting Chief Executive Officer, Director $5.91M Mar 3, 2022
John A. Fry Director $1.25M Jun 19, 2023
Hersh Kozlov Director $1.2M Jun 19, 2023
Howard L. Weiner Director $1.2M Jun 19, 2023
Keith R. Harris Director $1.2M Jun 19, 2023
Chandresh Harjivan Director $1.2M Jun 19, 2023
Michael Stephen Tung Evp & Cfo $956K May 19, 2025
Steven L. Tuch Chief Financial Officer $882K Feb 27, 2024
Fahed Al-Marzooqi Director $225K Jun 10, 2025
Anne M. Phillips Director $180K Jun 10, 2025
Daniel K. Spiegelman Director $166K Jun 10, 2025
Barry K. Brown Chief Accounting Officer $68.00 Apr 11, 2025
Jonathan Isaacsohn Director Aug 17, 2022
Tahnoon Bin Al-Nahyan 10%+ Owner May 31, 2022
G42 Investments AI Holdings RSC Ltd. Director, 10%+ Owner May 31, 2022
Baker Bros. Advisors Lp Director Sep 3, 2025
Raymond Cheong Director Feb 27, 2024

Recent Insider Transactions by Companies or Individuals for vTv Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.